Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases
โ Scribed by Eeva-Liisa Helkala; Veikko Laulumaa; Hilkka Soininen; Paavo J. Riekkinen
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 439 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
โฆ Synopsis
Alzheimer's and Parkinson's diseases are associated with cognitive impairment, although the pattern of cognitive dysfunction is not identical. We investigated the recall and recognition memory of 18 patients with idiopathic Parkinson's disease (PD) and of 32 patients with probable Alzheimer's disease (AD). In the list-learning test using Buschke's selective reminding method, PD patients showed superior delayed recognition memory capability compared to AD patients, whereas immediate recall did not differ in the two groups. In the delayed story recall, PD patients were also able to benefit from rehearsal and probe more than AD patients. The results suggest that PD patients are able to bind information better into long-term storage than are AD patients. This may be due to better function in PD of the entorhinal cortex and hippocampus.
๐ SIMILAR VOLUMES
Objective. To compare the proยฎle of neuropsychiatric symptoms in patients with Parkinson's disease with dementia (PDD) and patients with Alzheimer's disease (AD). Design. Cross-sectional survey of a population-based sample of patients with PDD and AD patients matched for age, sex, and Mini-Mental S
Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control
## Objective: To compare the prevalence of fatigue in patients with parkinson's disease (pd) with that in healthy elderly people and to explore the suggestion that fatigue is an independent symptom of pd. ## Design: Questionnaire survey. ## Setting: Community-based population. ## Patients and
The mitochondrial DNA (mtDNA) sequence was determined on 3 patients with Alzheimer's disease (AD) exhibiting AD plus Parkinson's disease (PD) neuropathologic changes and one patient with PD. Patient mtDNA sequences were compared to the standard Cambridge sequence to identify base changes. In the fir
Alzheimer's disease is a disorder which is typified by a deterioration in cognition and a range of behavioural problems which result in a loss of functional ability and often necessitate transfer to residential care. This article looks at a growing body of research which is revealing the presence of